CN Patent

CN106146585B — 氘修饰的脲苷衍生物

Assigned to Chia Tai Tianqing Pharmaceutical Group Co Ltd · Expires 2019-05-28 · 7y expired

What this patent protects

本发明属于药物化学领域，涉及氘修饰的脲苷衍生物，具体涉及如式Ⅰ所示的氘修饰的(2'R)‑2'‑脱氧‑2'‑氟‑2'‑甲基脲苷，及其在制备索非布韦或氘代索非布韦中的应用。所述氘修饰的(2'R)‑2'‑脱氧‑2'‑氟‑2'‑甲基脲苷性质稳定，用于制备索非布韦或氘代索非布韦收率较高。

USPTO Abstract

本发明属于药物化学领域，涉及氘修饰的脲苷衍生物，具体涉及如式Ⅰ所示的氘修饰的(2'R)‑2'‑脱氧‑2'‑氟‑2'‑甲基脲苷，及其在制备索非布韦或氘代索非布韦中的应用。所述氘修饰的(2'R)‑2'‑脱氧‑2'‑氟‑2'‑甲基脲苷性质稳定，用于制备索非布韦或氘代索非布韦收率较高。

Drugs covered by this patent

Patent Metadata

Patent number: CN106146585B
Jurisdiction: CN
Classification: —
Expires: 2019-05-28
Drug substance claim: No
Drug product claim: No
Assignee: Chia Tai Tianqing Pharmaceutical Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.